Cargando…
Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich
Given the large number of mild or asymptomatic SARS-CoV-2 cases, only population-based studies can provide reliable estimates of the magnitude of the pandemic. We therefore aimed to assess the sero-prevalence of SARS-CoV-2 in the Munich general population after the first wave of the pandemic. For th...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038115/ https://www.ncbi.nlm.nih.gov/pubmed/33808249 http://dx.doi.org/10.3390/ijerph18073572 |
_version_ | 1783677300762476544 |
---|---|
author | Pritsch, Michael Radon, Katja Bakuli, Abhishek Le Gleut, Ronan Olbrich, Laura Guggenbüehl Noller, Jessica Michelle Saathoff, Elmar Castelletti, Noemi Garí, Mercè Pütz, Peter Schälte, Yannik Frahnow, Turid Wölfel, Roman Rothe, Camilla Pletschette, Michel Metaxa, Dafni Forster, Felix Thiel, Verena Rieß, Friedrich Diefenbach, Maximilian Nikolaus Fröschl, Günter Bruger, Jan Winter, Simon Frese, Jonathan Puchinger, Kerstin Brand, Isabel Kroidl, Inge Hasenauer, Jan Fuchs, Christiane Wieser, Andreas Hoelscher, Michael |
author_facet | Pritsch, Michael Radon, Katja Bakuli, Abhishek Le Gleut, Ronan Olbrich, Laura Guggenbüehl Noller, Jessica Michelle Saathoff, Elmar Castelletti, Noemi Garí, Mercè Pütz, Peter Schälte, Yannik Frahnow, Turid Wölfel, Roman Rothe, Camilla Pletschette, Michel Metaxa, Dafni Forster, Felix Thiel, Verena Rieß, Friedrich Diefenbach, Maximilian Nikolaus Fröschl, Günter Bruger, Jan Winter, Simon Frese, Jonathan Puchinger, Kerstin Brand, Isabel Kroidl, Inge Hasenauer, Jan Fuchs, Christiane Wieser, Andreas Hoelscher, Michael |
author_sort | Pritsch, Michael |
collection | PubMed |
description | Given the large number of mild or asymptomatic SARS-CoV-2 cases, only population-based studies can provide reliable estimates of the magnitude of the pandemic. We therefore aimed to assess the sero-prevalence of SARS-CoV-2 in the Munich general population after the first wave of the pandemic. For this purpose, we drew a representative sample of 2994 private households and invited household members 14 years and older to complete questionnaires and to provide blood samples. SARS-CoV-2 seropositivity was defined as Roche N pan-Ig ≥ 0.4218. We adjusted the prevalence for the sampling design, sensitivity, and specificity. We investigated risk factors for SARS-CoV-2 seropositivity and geospatial transmission patterns by generalized linear mixed models and permutation tests. Seropositivity for SARS-CoV-2-specific antibodies was 1.82% (95% confidence interval (CI) 1.28–2.37%) as compared to 0.46% PCR-positive cases officially registered in Munich. Loss of the sense of smell or taste was associated with seropositivity (odds ratio (OR) 47.4; 95% CI 7.2–307.0) and infections clustered within households. By this first population-based study on SARS-CoV-2 prevalence in a large German municipality not affected by a superspreading event, we could show that at least one in four cases in private households was reported and known to the health authorities. These results will help authorities to estimate the true burden of disease in the population and to take evidence-based decisions on public health measures. |
format | Online Article Text |
id | pubmed-8038115 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80381152021-04-12 Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich Pritsch, Michael Radon, Katja Bakuli, Abhishek Le Gleut, Ronan Olbrich, Laura Guggenbüehl Noller, Jessica Michelle Saathoff, Elmar Castelletti, Noemi Garí, Mercè Pütz, Peter Schälte, Yannik Frahnow, Turid Wölfel, Roman Rothe, Camilla Pletschette, Michel Metaxa, Dafni Forster, Felix Thiel, Verena Rieß, Friedrich Diefenbach, Maximilian Nikolaus Fröschl, Günter Bruger, Jan Winter, Simon Frese, Jonathan Puchinger, Kerstin Brand, Isabel Kroidl, Inge Hasenauer, Jan Fuchs, Christiane Wieser, Andreas Hoelscher, Michael Int J Environ Res Public Health Article Given the large number of mild or asymptomatic SARS-CoV-2 cases, only population-based studies can provide reliable estimates of the magnitude of the pandemic. We therefore aimed to assess the sero-prevalence of SARS-CoV-2 in the Munich general population after the first wave of the pandemic. For this purpose, we drew a representative sample of 2994 private households and invited household members 14 years and older to complete questionnaires and to provide blood samples. SARS-CoV-2 seropositivity was defined as Roche N pan-Ig ≥ 0.4218. We adjusted the prevalence for the sampling design, sensitivity, and specificity. We investigated risk factors for SARS-CoV-2 seropositivity and geospatial transmission patterns by generalized linear mixed models and permutation tests. Seropositivity for SARS-CoV-2-specific antibodies was 1.82% (95% confidence interval (CI) 1.28–2.37%) as compared to 0.46% PCR-positive cases officially registered in Munich. Loss of the sense of smell or taste was associated with seropositivity (odds ratio (OR) 47.4; 95% CI 7.2–307.0) and infections clustered within households. By this first population-based study on SARS-CoV-2 prevalence in a large German municipality not affected by a superspreading event, we could show that at least one in four cases in private households was reported and known to the health authorities. These results will help authorities to estimate the true burden of disease in the population and to take evidence-based decisions on public health measures. MDPI 2021-03-30 /pmc/articles/PMC8038115/ /pubmed/33808249 http://dx.doi.org/10.3390/ijerph18073572 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pritsch, Michael Radon, Katja Bakuli, Abhishek Le Gleut, Ronan Olbrich, Laura Guggenbüehl Noller, Jessica Michelle Saathoff, Elmar Castelletti, Noemi Garí, Mercè Pütz, Peter Schälte, Yannik Frahnow, Turid Wölfel, Roman Rothe, Camilla Pletschette, Michel Metaxa, Dafni Forster, Felix Thiel, Verena Rieß, Friedrich Diefenbach, Maximilian Nikolaus Fröschl, Günter Bruger, Jan Winter, Simon Frese, Jonathan Puchinger, Kerstin Brand, Isabel Kroidl, Inge Hasenauer, Jan Fuchs, Christiane Wieser, Andreas Hoelscher, Michael Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich |
title | Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich |
title_full | Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich |
title_fullStr | Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich |
title_full_unstemmed | Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich |
title_short | Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich |
title_sort | prevalence and risk factors of infection in the representative covid-19 cohort munich |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038115/ https://www.ncbi.nlm.nih.gov/pubmed/33808249 http://dx.doi.org/10.3390/ijerph18073572 |
work_keys_str_mv | AT pritschmichael prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT radonkatja prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT bakuliabhishek prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT legleutronan prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT olbrichlaura prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT guggenbuehlnollerjessicamichelle prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT saathoffelmar prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT castellettinoemi prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT garimerce prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT putzpeter prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT schalteyannik prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT frahnowturid prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT wolfelroman prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT rothecamilla prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT pletschettemichel prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT metaxadafni prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT forsterfelix prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT thielverena prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT rießfriedrich prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT diefenbachmaximiliannikolaus prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT froschlgunter prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT brugerjan prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT wintersimon prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT fresejonathan prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT puchingerkerstin prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT brandisabel prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT kroidlinge prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT hasenauerjan prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT fuchschristiane prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT wieserandreas prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT hoelschermichael prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich AT prevalenceandriskfactorsofinfectionintherepresentativecovid19cohortmunich |